Diabetic kidney disease with albuminuria — ABIM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Add an SGLT2 inhibitor while continuing ACE inhibition
SGLT2 inhibition reduces kidney and cardiovascular events in albuminuric diabetic CKD at this eGFR and is layered on ACE inhibition. A modest initial eGFR dip is expected, while dual RAS blockade is harmful; protein loading and thiazide monotherapy do not provide the same disease-modifying benefit.
Reference: KDIGO 2024 Clinical Practice Guideline for Chronic Kidney Disease: https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf